Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vulvar Diseases 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1

Interventions

Metformin 7Exercise 4Inositol 3semaglutide 2Tablets 2Spironolactone 2Progesterone 2xin-kang 1mirabegron 1mazdutide 1maltodextrin 1drospirenone 1dapagliflozin 1artenimol 1Water 1Vitamin D 1Transcranial Direct Current Stimulation 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Sitagliptin Phosphate 1Quercetin 1Physical Examination 1Observation 1Magnesium 1Liraglutide 1Letrozole 1Ketones 1In Vitro Oocyte Maturation Techniques 1Hydroquinones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Polycystic Ovary Syndrome × artenimol × Clear all
NCT06842524 2025-04-20

Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

Shanghai Zhongshan Hospital

Phase 2 Recruiting
150 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡